A novel role for interleukin 32 in cholestasis
Open Access
- 23 November 2021
- journal article
- letter
- Published by Wiley in Clinical and Translational Medicine
- Vol. 11 (11) , e594
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81770583, 82000545, 81922012)
- Natural Science Foundation of Chongqing Municipality (cstc2016jcyjA0149)
This publication has 10 references indexed in Scilit:
- Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virusNature Communications, 2018
- β‐Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasisHepatology, 2018
- Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory responseJCI Insight, 2017
- Interleukin-32α Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 BiogenesisTheranostics, 2017
- Interleukin-32γ Suppresses Allergic Airway Inflammation in Mouse Models of AsthmaAmerican Journal of Respiratory Cell and Molecular Biology, 2014
- Interleukin-32 Increases Human Gastric Cancer Cell Invasion Associated with Tumor Progression and MetastasisClinical Cancer Research, 2014
- Bile Acids Induce Inflammatory Genes in HepatocytesThe American Journal of Pathology, 2011
- New molecular insights into the mechanisms of cholestasisJournal of Hepatology, 2009
- Interleukin-32Immunity, 2005
- A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid BiosynthesisMolecular Cell, 2000